Accendra Health, Inc. (ACH) News
Follow Accendra Health, Inc. (ACH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Accendra Health Q3 Revenue $601.8 Million, Adjusted EBITDA $47.8 Million
Q3 revenue was $601.8 million versus an IBES estimate of $617.4 million; adjusted EBITDA was $47.8 million versus an estimate of $74.1 million.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
Accendra Health Sees 2026 EBITDA Up to 30% Below Prior Outlook
Accendra Health expects 2026 net revenue at the bottom end of its prior $2.45B–$2.55B range and adjusted EBITDA up to 30% below the prior $310M midpoint. No prior-period comparison was provided.
EARNINGS | Nov 05, 2026, 09:01 PM UTC
M
Accendra Health Reports Third-Quarter 2026 Financial Results
Accendra Health reported results for the quarter ended September 30, 2026. The supplied body is truncated and provides no financial figures.
EQUITY | Nov 05, 2026, 09:01 PM UTC
L
ACH - Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
ACH - Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
NEWS | Sep 17, 2026, 10:37 AM UTC
L
Accendra Health drops ATM plan, nets $45M from asset sales
Accendra Health says it will not put in place an at-the-market issuance program, expects about $45 million in cash from two non-core asset sales, and targets a CEO successor by mid-September 2026.
EARNINGS | Aug 17, 2026, 10:36 AM UTC
H
Analysts Downgrade ACH, ACVA, ALL, UAA
Multiple stocks downgraded by analysts
EQUITY | Aug 11, 2026, 11:05 AM UTC
L
Accendra Health Lowers FY2026 Sales Guidance from $2.550B-$2.650B to $2.450B-$2.550B vs $2.574B Est
Accendra Health (NYSE: ACH ) lowers FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.450 billion-$2.550 billion vs $2.574 billion estimate.
EARNINGS | Aug 10, 2026, 10:46 AM UTC
H
Closing Bell Movers: JB Hunt up 8% after Q2 earnings beat
Rapid momentum shifts in the Tech ecosystem continued to dominate headlines on Wednesday, with broad-based selling in the semiconductor, chip equipment, and memory names being offset by renewed strength among the hypersc
RATES | Jul 15, 2026, 11:34 PM UTC
L
ACH Announces Offer Results
Accendra Health announces expiration and final results of offers and consent solicitations
EARNINGS | Jun 24, 2026, 09:14 AM UTC